Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer

被引：3
|
作者：
Bertino, Erin [1 ]
Villalona-Calero, Miguel A. [1 ]
Ross, Patrick [2 ]
Grever, Michael [3 ]
Otterson, Gregory A. [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
ANNALS OF THORACIC SURGERY | 2011年 / 91卷 / 02期
关键词：
TRIAL; SURGERY; CHEMOTHERAPY;
D O I：
10.1016/j.athoracsur.2010.07.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [21] Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    Chiu, Li-Chung
    Lin, Shu-Min
    Lo, Yu-Lun
    Kuo, Scott Chih-Hsi
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (07)
  • [22] CNS efficacy of atezolizumab, bevacizumab, carboplatin and paclitaxel in patients with non-small cell lung cancer and actionable mutations
    Rathbone, M.
    O'Hagan, C.
    Khan, A.
    Cook, T.
    Rose, S.
    Heseltine, J.
    Howell, M.
    Wong, H.
    Escriu, C.
    ANNALS OF ONCOLOGY, 2023, 34
  • [23] Cost effectiveness of the addition of bevacizumab to carboplatin and paclitaxel for medicare beneficiaries with advanced non-small cell lung cancer
    Fanucchi, Michael
    Clinton, Chelsea
    Mathur-Wagh, Usha
    Twyne, Ellen
    Reisch, Karen
    Muinde, Ruth
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S427 - S427
  • [24] Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer
    Kubota, Tetsuya
    Okano, Yoshio
    Sakai, Mizu
    Takaoka, Masato
    Tsukuda, Tsukie
    Anabuki, Kazuki
    Kawase, Shigeo
    Miyamoto, Shintaro
    Ohnishi, Hiroshi
    Hatakeyama, Nobuo
    Machida, Hisanori
    Urata, Tomoyuki
    Yamamoto, Akira
    Ogushi, Fumitaka
    Yokoyama, Akihito
    ANTICANCER RESEARCH, 2016, 36 (01) : 307 - 312
  • [25] PHASE 1 STUDY OF IPILIMUMAB IN COMBINATION WITH PACLITAXEL/CARBOPLATIN IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Nokihara, Hihoshi
    Horinouchi, Hidehito
    Yagishita, Shigehiro
    Kitazono, Satoru
    Mizugaki, Hidenori
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Iida, Mayumi
    Tokudome, Takuto
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S911 - S911
  • [26] Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study
    Omori, Miwako
    Minegishi, Yuji
    Uruga, Hironori
    Fukuizumi, Aya
    Isobe, Kazutoshi
    Izumi, Shinyu
    Koyama, Ryo
    Bando, Masashi
    Sugiyama, Haruhito
    Takahashi, Kazuhisa
    Gemma, Akihiko
    Homma, Sakae
    Sugiyama, Yukihiko
    Kishi, Kazuma
    RESPIRATORY INVESTIGATION, 2023, 61 (05) : 625 - 631
  • [27] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kanat, Ozkan
    Cubukcu, Erdem
    Cubukcu, Sinem
    Aksoy, Savas
    Canhoroz, Mustafa
    Karadag, Oya
    Alkis, Nihan
    Manavolglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
  • [28] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Sadic, Murat
    Alavi, Abass
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [29] Induction paclitaxel/carboplatin in early stage non-small cell lung cancer
    Pisters, KMW
    Kris, MG
    Bunn, PA
    Johnson, DH
    Ruckdeschel, JC
    Crowley, JJ
    Ginsberg, RJ
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 41 - 44
  • [30] Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?
    Saha, Antonio
    Rudd, Robin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (02) : 165 - 173
12345